Suppr超能文献

起始密码子的交替选择产生具有肿瘤抑制活性的冯·希佩尔-林道基因的生物活性产物。

Alternate choice of initiation codon produces a biologically active product of the von Hippel Lindau gene with tumor suppressor activity.

作者信息

Blankenship C, Naglich J G, Whaley J M, Seizinger B, Kley N

机构信息

Department of Functional Genomics, Genome Therapeutics Corporation, Waltham, Massachusetts 02154, USA.

出版信息

Oncogene. 1999 Feb 25;18(8):1529-35. doi: 10.1038/sj.onc.1202473.

Abstract

The VHL tumor suppressor gene has previously been reported to encode a protein of 213 amino acid residues. Here we report the identification of a second major VHL gene product with an apparent molecular weight of 18 kD, pVHL18, which appears to arise from alternate translation initiation at a second AUG codon (codon 54) within the VHL open reading frame. In vitro and in vivo studies indicate that the internal codon in the VHL mRNA is necessary and sufficient for production of pVHL18. pVHL18 can bind to elongin B, elongin C, and Hs-CUL2. When reintroduced into renal carcinoma cells that lack a wild-type VHL allele, pVHL18 suppresses basal levels of VEGF expression, restores hypoxia-inducibility of VEGF expression, and inhibits tumor formation in nude mice. These data strongly support the existence of two distinct VHL gene products in VHL tumor suppression.

摘要

VHL肿瘤抑制基因先前已被报道编码一种由213个氨基酸残基组成的蛋白质。在此我们报告鉴定出第二种主要的VHL基因产物,其表观分子量为18 kD,即pVHL18,它似乎源自VHL开放阅读框内第二个AUG密码子(第54位密码子)处的可变翻译起始。体外和体内研究表明,VHL mRNA中的内部密码子对于pVHL18的产生是必要且充分的。pVHL18可以与延伸因子B、延伸因子C和Hs-CUL2结合。当重新导入缺乏野生型VHL等位基因的肾癌细胞中时,pVHL18可抑制VEGF表达的基础水平,恢复VEGF表达的缺氧诱导性,并抑制裸鼠体内的肿瘤形成。这些数据有力地支持了在VHL肿瘤抑制中存在两种不同的VHL基因产物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验